Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Mulu Tesfay

Concepts (67)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

The timeline below shows the dates (blue tick marks) of publications associated with Mulu Tesfay's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Mulu Tesfay has written about over time.
eIF-2 Kinase, 1 publications between 2007 and 2007, average publication date December 2007. RNA Caps, 1 publications between 2007 and 2007, average publication date December 2007. RNA, Messenger, 1 publications between 2007 and 2007, average publication date December 2007. Interferon-alpha, 2 publications between 2007 and 2008, average publication date April 2008. Protein Biosynthesis, 2 publications between 2007 and 2008, average publication date April 2008. Interferon-beta, 3 publications between 2007 and 2013, average publication date November 2009. Polyethylene Glycols, 1 publications between 2013 and 2013, average publication date January 2013. Vesicular stomatitis Indiana virus, 1 publications between 2013 and 2013, average publication date January 2013. Viremia, 1 publications between 2013 and 2013, average publication date January 2013. DNA Primers, 2 publications between 2013 and 2014, average publication date August 2013. Green Fluorescent Proteins, 2 publications between 2013 and 2014, average publication date August 2013. Neutralization Tests, 2 publications between 2013 and 2014, average publication date August 2013. Vero Cells, 2 publications between 2013 and 2014, average publication date August 2013. Complement System Proteins, 1 publications between 2014 and 2014, average publication date March 2014. Immunoglobulin M, 1 publications between 2014 and 2014, average publication date March 2014. Vesiculovirus, 1 publications between 2014 and 2014, average publication date March 2014. Oncolytic Virotherapy, 3 publications between 2013 and 2025, average publication date August 2017. Carcinoma, Pancreatic Ductal, 1 publications between 2024 and 2024, average publication date February 2024. Oncolytic Viruses, 1 publications between 2025 and 2025, average publication date August 2025.

To see the data from this visualization as text, click here.
Tesfay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_